MRESIVA Trademark

Trademark Overview

On Thursday, June 29, 2023, a trademark application was filed for MRESIVA with the United States Patent and Trademark Office. The USPTO has given the MRESIVA trademark a serial number of 98064421. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, June 11, 2024. This trademark is owned by ModernaTx, Inc.. The MRESIVA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
mresiva

General Information

Serial Number98064421
Word MarkMRESIVA
Filing DateThursday, June 29, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, June 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2023

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameModernaTx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, July 3, 2023NEW APPLICATION ENTERED
Monday, July 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 17, 2023ASSIGNED TO EXAMINER
Wednesday, October 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, March 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, March 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, March 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2024SOU EXTENSION 1 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 11, 2024SOU EXTENSION 1 FILED

Related Keywords

mresiva human vaccines